Re: Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia: Editorial comment

Steven A. Kaplan

doi:10.1016/j.juro.2014.11.042

Re: Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia: Editorial comment

Steven A. Kaplan

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	731-732
Number of pages	2
Journal	Journal of Urology
Volume	193
Issue number	2
DOIs	https://doi.org/10.1016/j.juro.2014.11.042
State	Published - 1 Feb 2015

Access to Document

10.1016/j.juro.2014.11.042

Cite this

@article{0a6556cd841242f287934b87f7b07ba9,

title = "Re: Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia: Editorial comment",

author = "Kaplan, {Steven A.}",

year = "2015",

month = feb,

day = "1",

doi = "10.1016/j.juro.2014.11.042",

language = "English",

volume = "193",

pages = "731--732",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "2",

}

TY - JOUR

T1 - Re

T2 - Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia: Editorial comment

AU - Kaplan, Steven A.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84920660784&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.11.042

DO - 10.1016/j.juro.2014.11.042

M3 - Comment/debate

C2 - 25617311

AN - SCOPUS:84920660784

SN - 0022-5347

VL - 193

SP - 731

EP - 732

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -